相似文献
1
Adverse drug reactions.
BMJ. 1998 Apr 25;316(7140):1295-8. doi: 10.1136/bmj.316.7140.1295.
2
Mechanism of idiosyncratic drug reactions: reactive metabolite formation, protein binding and the regulation of the immune system.
Curr Drug Metab. 2002 Aug;3(4):367-77. doi: 10.2174/1389200023337333.
3
Role of bioactivation in drug-induced hypersensitivity reactions.
AAPS J. 2006 Feb 3;8(1):E55-64. doi: 10.1208/aapsj080107.
4
Metabolomics in drug intolerance.
Curr Drug Metab. 2009 Nov;10(9):947-55. doi: 10.2174/138920009790711823.
5
Metabolic activation in drug allergies.
Toxicology. 2001 Feb 2;158(1-2):11-23. doi: 10.1016/s0300-483x(00)00397-8.
6
Reactive metabolites and adverse drug reactions: clinical considerations.
Clin Rev Allergy Immunol. 2003 Jun;24(3):229-38. doi: 10.1385/CRIAI:24:3:229.
7
Noncovalent interactions of drugs with immune receptors may mediate drug-induced hypersensitivity reactions.
AAPS J. 2006 Mar 17;8(1):E160-5. doi: 10.1208/aapsj080119.
8
How to predict adverse immune reactions induced by pharmaceutical compounds.
Trends Biotechnol. 1995 Aug;13(8):283-5. doi: 10.1016/S0167-7799(00)88965-9.
9
Immunological principles of T-cell-mediated adverse drug reactions in skin.
Expert Opin Drug Saf. 2007 Mar;6(2):109-24. doi: 10.1517/14740338.6.2.109.
10
Patient ethnicity and the risk of immune-mediated adverse drug reactions.
Pharmacogenomics. 2017 Oct;18(15):1375-1378. doi: 10.2217/pgs-2017-0124. Epub 2017 Oct 4.
引用本文的文献
1
Role of pharmacogenomics for prevention of hypersensitivity reactions induced by aromatic antiseizure medications.
Front Pharmacol. 2025 Aug 12;16:1640401. doi: 10.3389/fphar.2025.1640401. eCollection 2025.
2
Exploring common mechanisms of adverse drug reactions and disease phenotypes through network-based analysis.
Cell Rep Methods. 2025 Feb 24;5(2):100990. doi: 10.1016/j.crmeth.2025.100990. Epub 2025 Feb 14.
3
AI-Based Computational Methods in Early Drug Discovery and Post Market Drug Assessment: A Survey.
IEEE Trans Comput Biol Bioinform. 2025 Jan-Feb;22(1):97-115. doi: 10.1109/TCBB.2024.3492708.
4
DDInter 2.0: an enhanced drug interaction resource with expanded data coverage, new interaction types, and improved user interface.
Nucleic Acids Res. 2025 Jan 6;53(D1):D1356-D1362. doi: 10.1093/nar/gkae726.
5
[Pharmacovigilance of vaccines against COVID-19 in community pharmacies. Results after the second dose and comparison between both].
Farm Comunitarios. 2023 Jun 1;15(3):5-16. doi: 10.33620/FC.2173-9218.(2023).21. eCollection 2023 Jul 15.
6
[Pharmacovigilance of vaccines against COVID-19 in community pharmacies. Results with the first dose].
Farm Comunitarios. 2023 Jan 2;15(1):22-40. doi: 10.33620/FC.2173-9218.(2023).04.
7
A review of serious adverse events linked with GLP-1 agonists in type 2 diabetes mellitus and obesity treatment.
Pharmacol Rep. 2024 Oct;76(5):981-990. doi: 10.1007/s43440-024-00629-x. Epub 2024 Aug 2.
8
Identifying strategies to improve adverse drug reporting through key informant interviews among community pharmacists in a developing country.
Sci Rep. 2024 Jul 22;14(1):16821. doi: 10.1038/s41598-024-67263-8.
9
Genetic Variants in the and Gene Drug Transporters Involved in Gefitinib-Associated Adverse Reaction: A Systematic Review and Meta-Analysis.
Genes (Basel). 2024 May 7;15(5):591. doi: 10.3390/genes15050591.
10
A Drug Safety Briefing (II) in Transplantation from Real-World Individual Pharmacotherapy Management to Prevent Patient and Graft from Polypharmacy Risks at the Very Earliest Stage.
Pharmaceuticals (Basel). 2024 Feb 25;17(3):294. doi: 10.3390/ph17030294.
本文引用的文献
1
2
3
Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines.
Br J Clin Pharmacol. 1996 Oct;42(4):423-9. doi: 10.1046/j.1365-2125.1996.04376.x.
4
Idiosyncratic drug reactions. Metabolic bioactivation as a pathogenic mechanism.
Clin Pharmacokinet. 1996 Sep;31(3):215-30. doi: 10.2165/00003088-199631030-00005.
5
The role of cytochrome P450 enzymes in hepatic and extrahepatic human drug toxicity.
Pharmacol Ther. 1995;68(3):385-424. doi: 10.1016/0163-7258(95)02013-6.
6
Intracellular glutathione in the peripheral blood cells of HIV-infected patients: failure to show a deficiency.
AIDS. 1996 May;10(5):501-7. doi: 10.1097/00002030-199605000-00008.
7
Role of CYP2E1 in the hepatotoxicity of acetaminophen.
J Biol Chem. 1996 May 17;271(20):12063-7. doi: 10.1074/jbc.271.20.12063.
8
Fialuridine and its metabolites inhibit DNA polymerase gamma at sites of multiple adjacent analog incorporation, decrease mtDNA abundance, and cause mitochondrial structural defects in cultured hepatoblasts.
Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3592-7. doi: 10.1073/pnas.93.8.3592.
9
Introducing MEDWatch. A new approach to reporting medication and device adverse effects and product problems.
JAMA. 1993 Jun 2;269(21):2765-8. doi: 10.1001/jama.269.21.2765.
10
Liver failure induced by paracetamol.
BMJ. 1993 Jan 16;306(6871):157-8. doi: 10.1136/bmj.306.6871.157.
Zotero 插件